Metastatic Lung Adenocarcinoma Presenting After Kidney Transplant
This lung cancer diagnosis at a glance
- Subtype
- Adenocarcinoma
- Biomarkers
- TTF-1 positive
- Sex
- Male
- Spread to
- bone marrow|spine|bony pelvis
- Treatment
- palliative care
- Outcome
- In Memory
Treatment course, step by step
- He was not fit enough for chemotherapy and received palliative care.
What happened, in summary
A 52-year-old man presented with right-leg swelling 4 months after a kidney transplant. He had previously smoked for 40 pack-years, although pre-transplant screening had not identified cancer. During admission, he developed severe red-cell destruction, low platelets, and a continuing need for blood transfusions. Several transplant-related, infectious, autoimmune, and complement-related causes were considered and treated, but his condition continued to worsen.
He then developed fever, breathlessness, and back pain. Chest imaging showed a spiculated mass in the right lower lung with mediastinal nodes and pleural and pericardial fluid. MRI found diffuse disease in the spine and bony pelvis. A bone-marrow biopsy showed extensive necrosis and metastatic adenocarcinoma. The malignant cells were TTF-1 positive, supporting a lung primary.
His functional condition declined rapidly from independent living to needing help with most activities within 3 weeks. He was not well enough to receive chemotherapy and was transitioned to palliative care. He died 1 week after the diagnosis. The blood disorder was considered most likely a paraneoplastic complication of the disseminated lung cancer.
Where this story comes from
This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full
How we source and attribute stories Accuracy and limitations
Collections this story belongs to
- Metastatic Lung Cancer 25 stories
- Palliative Care for Lung Cancer 12 stories
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer